Prostate Cancers

16 registered clinical trials studyying Prostate Cancers — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Using FAPI PET/MRI to Evaluate Prostate Cancer NCT06675357	University of Wisconsin, Madison	Phase 2
Recruiting	The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and NCT06717295	Javier Toledo	—
Recruiting	To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the NCT06970275	XEOS Medical	—
Recruiting	Early Phase Study of KESONOTIDE™in Participants With Solid Tumours NCT06926075	Filamon LTD	Phase 1 / Phase 2
Not Yet Recruiting	PRostate Cancer Enhanced Diagnosis by Calibration Technology NCT06607783	Gold Standard Phantoms	—
Active Not Recruiting	A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations NCT07038369	Atavistik Bio, Inc	Phase 1
Not Yet Recruiting	Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial NCT06915909	East and North Hertfordshire NHS Trust	N/A
Recruiting	Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada NCT06960291	University of Calgary	N/A
Recruiting	Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0. NCT06776172	University Hospital, Basel, Switzerland	N/A
Recruiting	Ivonescimab in the Treatment of Multiple Advanced Tumors NCT06683846	Fudan University	Phase 2
Recruiting	FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer NCT06636682	Cellvax Therapeutics Inc	Phase 2
Completed	Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen NCT06641219	Tomsk National Research Medical Center of the Russian Academy of Sciences	Phase 1
Recruiting	Comprehensive Outcomes for After Cancer Health NCT05349227	Pack Health	N/A
Active Not Recruiting	Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained NCT06929884	Qianfoshan Hospital	—
Withdrawn	Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patie NCT02810886	Jules Bordet Institute	Phase 2
Terminated	FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cance NCT00917865	David M. Schuster, MD	Phase 2